SNN

SNN

USD

Smith & Nephew SNATS Inc. Common Stock

$37.020+0.540 (1.480%)

Цена в режиме реального времени

Healthcare
Медицинские приборы
Великобритания

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$36.480

Максимум

$37.080

Минимум

$36.460

Объем

1.61M

Фундаментальные показатели компании

Рыночная капитализация

15.8B

Отрасль

Медицинские приборы

Страна

United Kingdom

Статистические данные торговли

Средний объем

0.67M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $23.69Текущая $37.020Максимум $38.79

Связанные новости

GlobeNewswire

Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices

Просмотреть больше
Smith+Nephew comparative study1 shows  PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
GlobeNewswire

UFC® and Smith+Nephew announce multi-year extension of partnership

Smith+Nephew to continue as UFC's Preferred Sports Medicine Technology Partner Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world's premier mixed martial arts organization, have

Просмотреть больше
UFC® and Smith+Nephew announce multi-year extension of partnership
Analyst Upgrades

Bernstein Downgrades Smith & Nephew to Market Perform, Announces $37.5 Price Target

Bernstein analyst Lisa Clive downgrades Smith & Nephew from Outperform to Market Perform and announces $37.5 price target.

Просмотреть больше
Bernstein Downgrades Smith & Nephew to Market Perform, Announces $37.5 Price Target
GlobeNewswire

Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT)

Просмотреть больше
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.